cAMP-dependent anion secretion to the cyst lumen has been reported to be mediated by the luminal cystic fibrosis transmembrane conductance regulator (CFTR) [27, 28] . This channel has a key role in cyst formation by secreting chloride to the cyst lumen and driving sodium and water secretion to the interior of the cysts [29] [30] [31] [32] .
AVP hormone and the CFTR chloride channel are important in the pathogenesis of ADPKD as key regulators of cyst expansion. The mechanism underlying this regulation has not been totally elucidated, although the CFTR chloride channel has been shown to contribute to disease progression by driving fluid secretion to the cyst lumen. Therefore, study of the possible modulation of AVP over CFTR and how they are related is fundamental to elucidate the pathophysiology of the disease. The aim of this study was to investigate the possible modulation of CFTR by AVP and the possible regulation of this interaction by PC-1.
Materials and Methods
Cell culture and treatments M1 cells (ATCC CRL-2038) originating from mouse cortical collecting ducts were used [33] . The cells were cultivated in Dulbecco's modified essential medium: nutrient mixture F12 (DMEM/F12, Invitrogen, catalog no. 11320-033) with 17.5 mM glucose, supplemented with 10% fetal bovine serum (FBS), 100 U/ ml penicillin, and 100 µg/ml streptomycin (GIBCO) at 37°C in a 5% CO 2 humidified atmosphere. Before each treatment, the cells were incubated with medium without FBS for 12 h. Hormonal treatment with 10 -7 M AVP ([Arg 8 ]-vasopressin acetate salt; Sigma, catalog no. V9879) was performed at different time points: 1, 2, 3, 4, 6, 8 and 24 h. The control group did not receive any hormonal treatment. After each treatment, total RNA or total protein was extracted.
Several drugs were used to increase intracellular cAMP: 100 µM 3-isobutyl-1-methylxanthine (IBMX) (catalog no. I5879), 5 µM forskolin (catalog no. F6886), and 100 µM 8Br-cAMP (catalog no. B5386). 5 µM H-89 (catalog no. # B5386) was used as protein kinase A (PKA) inhibitor. All drugs were purchased from Sigma.
Cell transfection M1 cells were grown to 80-90% confluence in a six-well plate and then transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Two micrograms of WT-GFP plasmid, which encodes wild-type PKD1 with an N-terminal GFP tag, were used per well (kindly provided by Dr Gregory Germino, Johns Hopkins University, Baltimore, MD, USA). Transfection only with the GFP vector plasmid (1 µg) (pEGFP-C1, catalog no. 6084-1, BD Biosciences) was used as transfection control. No significant changes in the parameters were observed in cells transfected only with the GFP vector plasmid (data not shown). Different plasmid concentrations were used because PC-1 is a large and difficult-to-express protein. Twentyfour hours after transfection, the cells were treated for an additional 24 h with 10 -7 M AVP as described above.
Protein extraction and immunoblotting
Cells were harvested and lysed with RIPA buffer: 50 mM Tris-HCl, 150 mM NaCl, 2 mM EDTA, 5 mM pyrophosphate, 5 mM sodium vanadate, 400 µM phenylmethanesulfonylfluoride (PMSF), 0.1% sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate, 1% Triton X-100, and 1× complete protease inhibitor cocktail (Roche Applied Science, catalog no. 11697498001). After homogenization by vortexing, the cells were rotated at 4°C for 1 h, followed by centrifugation at 13,000 × g at 4°C for 20 min. The supernatant was collected and the protein concentration was measured using the BCA protein kit assay (Pierce, catalog no. 23225). After incubation with 2× Laemmli buffer (Bio-Rad, catalog no. 161-0737) at 42°C for 30 min, 50 µg of each sample was separated by size using a regular SDS-PAGE technique with 4 -15% polyacrylamide gel. After SDS-PAGE, the proteins were electrophoretically transferred to a polyvinylidene fluoride membrane (Millipore, catalog no. IPVH00010) using the Bio-Rad transference apparatus. Nonspecific membrane sites were blocked using 5% nonfat milk solution for 1 h at room temperature. Anti-CFTR (1:2000) (University of North Carolina, antibody 217), anti-V2R (1:1000) (Santa Cruz, catalog no. sc-17933), anti-PC-1 (1:10,000) (Santa Cruz, catalog no. SC-130554), and anti-GAPDH (1:10,000) (Santa Cruz, catalog no. sc-365062) 
RNA extraction and quantitation
Total RNA was extracted from M1 cells using an RNeasy Plus mini kit (Qiagen, catalog no. 74134) following the manufacturer's instructions. The RNA concentrations in the samples were determined in a spectrophotometer by absorption at 260 nm. The absorbance ratio 260 nm/280 nm was used to assess the purity of the samples and ratios close to 2 were considered acceptable for quantitative reverse transcriptionpolymerase chain reaction (qRT-PCR).
Real-time RT-PCR
Specific primers were designed for mouse CFTR qRT-PCR (156-bp product): sense 5′-TCA GTC CCA TAA AGT GGC CTG GAT-3′ and antisense 5′-ACA TGT TAA CTC CTG GAC CTG GCA-3′; mouse GAPDH (115-bp product) was used as control: sense 5′-TCA ACA GCA ACT CCC ACT CTT CCA-3′ and antisense 5′-ACC CTG TTG CTG TAG CCG TAT-TCA-3′. Reverse transcription was performed using 1 µg of total RNA with the Superscript III kit (Invitrogen) and the cDNA produced was submitted to the PCR with SYBR green (Applied Biosystems) in a thermal cycler 7500 (Applied Biosystems). The qRT-PCR protocol included 2 min at 95°C, 40 cycles of 15 s at 95°C, and 30 s at 60°C. The data were analyzed using 7500 software, version 2.0.5 (Applied Biosystems). Data analysis was performed using the 2 -∆∆Ct method.
Measurement of short-circuit currents (I sc )
Short-circuit current (Isc) measurements were performed in Ussing chambers mounted with Snapwell inserts (Corning, catalog no. 3407). Isc was measured with an EC-825 voltage-current clamp amplifier (World Precision Instruments) in voltage-clamp mode. Cells were cultured to confluence on Snapwell filters until the transepithelial resistance was equal to or higher than 600 Ω cm2, measured with an electrical resistance system (World Precision Instruments). Cell monolayers were bathed on the basolateral side with Krebs bicarbonate solution containing 115 mM NaCl, 25 mM NaHCO3, 2.4 mM K2HPO4, 1.2 mM CaCl2, 1.2 mM MgCl2, 0.4 mM KH2PO4, and 10 mM glucose (pH 7.4). A modified Krebs bicarbonate solution containing 2.0 mM Na-gluconate, 25 mM NaHCO3, 2.4 mM K2HPO4, 4.0 mM CaCl2, 1.2 mM MgCl2, 0.4 mM KH2PO4, and 1.6 mM glucose (pH 7.4) was used on the apical side [34] . The solutions were maintained at 37°C and gently bubbled with air so that they could be constantly recirculated. Amiloride (10 μM) was added to the apical solution and, after current stabilization, a cAMP cocktail (100 μM 8-Br-cAMP, 100 μM IBMX, and 20 μM forskolin) was applied to both the apical and basolateral solutions. The cAMP cocktail-stimulated current was blocked by 2 μM of CFTR inhibitor-172 (CFTR inh -172 (3-[(3-trifluoromethyl)phenyl]-5-[(4-carboxyphenyl)methylene]-2-thioxo-4-thiazolidinone), which is a specific channel blocker for CFTR that leads to rapid, reversible and voltage-independent inhibition. CFTRinh-172 acts as an allosteric inhibitor, targeting the cytoplasmic face of the CFTR protein at its nucleotide-binding domain 1 and maintaining a closed state of the related Cl -conductance [35, 36] .
Intracellular cAMP measurement M1 cells were cultured in 6-well plates and 12 h before treatment with AVP and IBMX, they were transferred to medium without FBS. Group transfections were performed 24 h before treatment, as described above. The cells were submitted to 10 -7 M AVP and 100 μM IBMX for 30 min and washed three times with PBS thereafter, followed by cAMP measurement using a cAMP enzyme immunoassay kit according to the manufacturer's protocol (Sigma, catalog no. CA200).
Statistical analysis
GraphPad Prism software version 5.01 (GraphPad Software) was used for the statistical analyses. The results are presented as means ± standard error of the mean. Statistical comparisons among the experimental groups were assessed by one-way ANOVA followed by the Dunnett post-test when required. When only two groups were compared, the unpaired t-test was used. The differences were considered significant when p < 0.05.
Results

The role of PC-1 in regulating CFTR expression
Cells transfected with PKD1 (Transf) had lower CFTR protein expression compared with cells not overexpressing PC-1 (Ctrl, 1.00 ± 0.00; Transf, 0.54 ± 0.10; n = 6, p < 0.01). GAPDH was used as internal control. The PC-1 blot demonstrates successful transfection (Fig. 1) . The immunoblotting analysis suggests, therefore, that CFTR expression can be regulated by PC-1, because the lack of its expression may contribute to CFTR upregulation.
Regulation of CFTR protein expression by AVP
CFTR protein expression was assessed at different time points after M1 cell treatment with 10 -7 M AVP hormone. CFTR expression was higher only 24 h after hormone treatment compared with the control group (Ctrl, 1.00 ± 0.00; 24 h, 1.49 ± 0.11; n = 6, p < 0.05). GAPDH was used as internal control ( Fig. 2A) . When the cells were transfected with PC-1, no significant changes in CFTR protein expression were observed at any time point after AVP treatment compared with the control group (Ctrl, 1.00 ± 0.00; 1 h, 0.88 ± 0.08; 2 h, 0.90 ± 0.10; 4 h, 1.04 ± 0.08; 6 h, 1.24 ± 0.08; 8 h, 1.21 ± 0.10; 24 h, 1.14 ± 0.25; n = 4, p > 0.05) (Fig.  2B) . Impact of increased intracellular cAMP in CFTR protein expression CFTR protein expression was assessed after different treatments of M1 cells designed to increase intracellular cAMP levels. Such treatments included AVP (10 -7 M), IBMX (100 µM), and the PKA inhibitor H-89 (5 µM). CFTR protein expression was higher in cells treated with AVP (1.41 ± 0.06) and IBMX (1.47 ± 0.08) compared with their control (Ctrl, 1.00 ± 0.00, n = 7, p < 0.05). Under IBMX + AVP, higher CFTR expression was more prominent (1.50 ± 0.15, n = 7, p < 0.01) (Fig. 3A) . No significant changes in CFTR protein expression were observed for H-89 + AVP-treated cells (1.17 ± 0.13) compared with its control group (1.00 ± 0.00, n = 7, p > 0.05) (Fig. 3A) . This observation demonstrates that cAMP and PKA may regulate the cell signaling involved in the control of CFTR protein expression. When PKD1 was inserted in this biological system, these differences were no longer significant, indicating that PC-1 was capable of abolishing CFTR modulation (n = 8, p > 0.05) (Fig. 3B) .
In other experimental groups, we used AVP (10 -7 M), forskolin (Fors) (5 µM), and the cAMP analogue 8Br-cAMP (100 µM) in order to increase the intracellular cAMP levels. Higher expression of CFTR protein was observed in the AVP, IBMX, Fors, Fors + AVP, 8Br-AMPc, and 8Br-AMPc + AVP groups (1.32 ± 0.06, 1.38 ± 0.16, 1.37 ± 0.05, 1.40 ± 0.12, 1.52 ± 0.06, 1.44 ± 0.21, respectively) compared with the control (1.00 ± 0.00, n = 6, p < 0.05) (Fig. 4A) . Once again, when PC-1 protein was present, a significant increase in CFTR expression could no longer be observed when the cells were stimulated with AVP or in the presence of a higher intracellular concentration of cAMP compared with the control group (n = 6, p > 0.05) (Fig. 4B ). These data suggest that PC-1 is a key protein to prevent CFTR upregulation when intracellular cAMP levels are increased.
The role of PC-1 in the regulation of V2R protein expression
The expression of V2R was assessed by western blotting in M1 cells with either a higher or basal expression of PC-1 in order to verify whether PC-1 can modulate its expression. A lower level V2R protein expression was observed in PKD1-transfected cells (0.65 ± 0.10) compared with control cells (1.00 ± 0.00; n = 5, p < 0.05) (Fig. 5) . This finding could explain, at least in part, why CFTR expression was not increased in cells with high PC-1 expression when stimulated with AVP.
CFTR short-circuit currents are modulated by AVP and PC-1
Ussing chambers were used to determine CFTR short-circuit currents (I sc ) in M1 cells previously polarized in transwell filters. When the cells polarize in tthose filters, they form a layer resembling an epithelium with transepithelial resistance. Thus, short circuit currents can be measured through this layer. Transepithelial conductance was determined in cells expressing PC-1 or not, as well as when submitted to AVP treatment for 24 h.
M1 cells not transfected with PKD1 presented higher transepithelial conductance when treated with AVP (1.36 ± 0.20) compared with their control (Ctrl, 0.82 ± 0.12, n = 8, p < 0.05) (Fig. 6A) . On the other hand, PKD1-transfected cells did not show any significant difference in transepithelial conductance after AVP treatment (0.95 ± 0.14) compared with control cells (1.12 ± 0.13, n = 6, p > 0.05) (Fig. 6B) . This observation indicates that PC-1 can prevent upregulation in CFTR short-circuit currents stimulated by AVP.
Effects of AVP hormone on CFTR mRNA expression CFTR mRNA expression was assessed in M1 cells by qRT-PCR at different time points after treatment with 10 -7 M AVP hormone. Significant CFTR mRNA upregulation was detected at 8 and 24 h in cells not transfected with PKD1 after this treatment (3.50 ± 0.88 and 2.74 ± 0.41, respectively) compared with the control cells (1 ± 0.00, n = 4, p < 0.05). Significant changes in CFTR mRNA expression were not observed 1 h, 2 h, 4 h, and 6 h after treatment with 10 -7 M AVP (1 h, 0.86 ± 0.13; 2 h, 1.18 ± 0.21; 4 h, 1.39 ± 0.32; 6 h, 1.31 ± 0.11, n = 4, p > 0.05) (Fig. 7A) . When the cells were transfected with PKD1, however, significant changes in CFTR mRNA expression were not found at all time points evaluated after treatment with 10 -7 M AVP (Ctrl, 1 ± 0.00; 1 h, 1.19 ± 0.22; 2 h, 1.95 ± 0.58; 4 h, 2.55 ± 0.99; 6 h, 2.56 ± 0.53, n = 4; 8 h, 1.39 ± 0.37; 24 h, 2.32 ± 0.35; n = 4, p > 0.05) compared with the control group (Fig. 7B) .
PC-1 is involved in the regulation of intracellular cAMP
The intracellular concentration of cAMP was assessed in PKD1-transfected and nontransfected cells by enzymatic immunoassay. Cells treated with AVP (10 -7 M) and IBMX (100 µM) presented a significant increase in cAMP levels (1.65 ± 0.10 and 3.22 ± 0.85, respectively) compared with the control group (0.95 ± 0.05, n = 5-8, p < 0.05). PKD1-transfected M1 cells did not show significant change in cAMP intracellular content when treated with 10 -7 M AVP (0.66 ± 0.08). Transfected cells treated with 100 µM IBMX, however, showed higher levels of intracellular cAMP (2.58 ± 0.72) compared with the transfected control group (Ctrl, 0.97 ± 0.21, n = 6, p < 0.05) (Fig. 8) .
Discussion
Cyst formation in ADPKD is caused by mutations in either PKD1 or PKD2 arising from the renal tubular segments. These cysts increase in number and get filled with fluid over time, compressing the surrounding nephrons and eventually leading to renal failure [37] . The channel responsible for driving the epithelial net secretion inward to the cyst is the CFTR chloride channel, which is therefore a determinant for cyst enlargement and disease progression. In this study, we have demonstrated that, in the presence of PC-1, the CFTR expression decreased 50% in mouse cortical collecting duct cells (M1 cells), suggesting the control but not abolishment of CFTR conductance by PC-1 in the distal part of the nephron Fig. 1) . Second hits represented by somatic mutations in the previously normal allele are thought to trigger cystogenesis in ADPKD, although other mechanisms have been shown to lead to cystogenesis under particular circumstances [38] . Accumulation of second hits could justify cystic transformation in mice with a heterozygous background. Haploinsufficiency seems to be important in this disease, because Pkd1-and Pkd2-haploinsufficient mice present increased cellular proliferation and interstitial fibrosis [39, 40] . Moreover, Pkd1-haploinsufficient mice display increased susceptibility to renal ischemia/reperfusion compared with wild-type controls and develop microcysts after such an insult, a finding not observed in wild-types [41] . Accordingly, PC-1 levels are important in as much as they reduce the rate of cell proliferation and induce resistance to programmed cell death in renal cells, allowing the constitution and maintenance of the tubular phenotype [42] . Physiologically, CFTR is responsible for cAMP-dependent chloride efflux across the apical membranes of collecting ducts [43, 44] . The secretion of chloride in this distal part of the nephron is thought to finely regulate extracellular fluid volume and composition and maintain urine formation during the cessation of glomerular filtration [45, 46] . Cellular mechanisms for chloride secretion in this segment are regulated by circulating hormones like AVP, a hormone that has been shown to stimulate chloride secretion through cAMPdependent PKA phosphorylation and activation of CFTR chloride channels [47, 48] .
AVP hormone has an important role in the aggravation of ADPKD by increasing intracellular cAMP and thereby stimulating cystic epithelial cell proliferation and chloride transepithelial secretion inward to the cyst, a process that leads to cyst growth. cAMPdependent proliferation is mediated by PKA and B-Raf, which stimulates MEK/ERK to upregulate the genes involved in cell proliferation [49] . In addition, opening of CFTR depends on cAMP phosphorylation [50] . In the present study, treatment of M1 distal tubule-derived cells with AVP increased CFTR protein and mRNA expression after 24 h, a stimulus that was abolished by the presence of PC-1 ( Fig. 2A and 2B ; Fig. 7A and 7B) and these results suggest that PKD1 functions as a physiological modulator of AVP renal response, a fact that could be relevant because CFTR is a modulator of other ion conductances and the control of its expression and function could avoid exacerbation of the renal response to hormonal stimulation in as the form of dehydration. In addition, these data suggest that AVP can modulate cyst progression through CFTR. This may be driven by an AVP-mediated increase in CFTR expression, leading to fluid secretion and cyst enlargement. PC-1 overexpression was capable of interfering in this modulation, demonstrating that PC-1 could minimize the deleterious effect of AVP [19, 23, 39, 51] .
Increased intracellular levels of cAMP promote cyst growth, an increase in kidney volume, and ADPKD progression [52, 53] . It is well documented that when PC-1 is mutated, as in ADPKD, the concentration of cAMP is abnormally high [15] . In this study, the stimulation of intracellular cAMP in M1 cells by IBMX, forskolin, and 8Br-cAMP led to a significant increase in CFTR protein expression. In the presence of PC-1, however, this modulation was abolished. PKA also seems to play an important role in the regulation of CFTR expression. 
